Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joe L. Guy"'
Autor:
Joe L, Guy, Gil G, Mor
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2255
Transcription factors orchestrate complex regulatory networks of gene expression. A better understanding of the common transcription factors, and their shared interactions, among a set of coregulated or differentially expressed genes can provide powe
Publikováno v:
Methods in Molecular Biology ISBN: 9781071611616
Transcription factors orchestrate complex regulatory networks of gene expression. A better understanding of the common transcription factors, and their shared interactions, among a set of coregulated or differentially expressed genes can provide powe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ec895608b4b5d6a05262865437437db
https://doi.org/10.1007/978-1-0716-1162-3_20
https://doi.org/10.1007/978-1-0716-1162-3_20
Autor:
Michal A. Olszewski, Joe L. Guy, Clifford S. Cho, Reliza McGinnis, Anutosh Ganguly, Hannah Garavaglia, Joe Dib, Ashley L Pepple, Amy E Felsted, Ryan Hubbard, Zhen Xu, Tejaswi Worlikar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Histotripsy, a novel image-guided, robotically assisted sonic therapy platform, is a non-invasive and non-thermal tumor ablation modality. We have previously shown that histotripsy potentiates profound innate and adaptive anti-tumor respon
Autor:
Kevin Quackenbush, John J. Arcaroli, Stacey M. Bagby, Joe L. Guy, Anna R Schreiber, Betelehem W. Yacob, Thomas Crowell, Thea Kalebic, Hadi Danaee, Wells A. Messersmith, Todd M. Pitts, Bradley Stringer, Anna Nguyen
Background Antibody-drug conjugates (ADCs) are an emerging technology consisting of an antibody, linker, and toxic agent, which have the potential to offer a targeted therapeutic approach. A novel target recently explored for the treatment of pancrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946602646f76f80a335f8b08e9935437
https://europepmc.org/articles/PMC6324574/
https://europepmc.org/articles/PMC6324574/
Autor:
John J. Arcaroli, Todd M. Pitts, Joe L. Guy, Stacey M. Bagby, Anna R Schreiber, Bradley Stringer, Anna Nguyen, Thea Kalebic, Thomas Crowell, Kevin Quackenbush, Wells A. Messersmith, Betelehem W. Yacob, Hadi Danaee
Publikováno v:
Molecular Cancer Therapeutics. 17:B050-B050
Background: Antibody-drug conjugates (ADCs) are an emerging technology consisting of antibody, linker, and toxic agent, which have the potential to offer a more targeted therapeutic approach than standard chemotherapy regimens. ADCs selectively bind